An experimental blood test developed at UCLA that uses gene activity data from immune cells was 93 percent accurate in predicting survival rates for people with advanced heart failure who had surgery to implant mechanical circulatory support devices.
Doctors might be able to better detect any disease or disorder that involves inflammation thanks to a new MRI imaging technology co-developed by faculty at Binghamton University, State University of New York.
Researchers at the Eli and Edythe Broad Center of Regenerative Medicine and Stem Cell Research at UCLA have discovered how high glucose levels - whether caused by diabetes or other factors - keep heart cells from maturing normally. Their findings help explain why babies born to women with diabetes are more likely to develop congenital heart disease.
An observational study by researchers at Mayo Clinic has found that increasing physical activity not only decreased the risk of death from all causes but also decreased the risk of death specifically from lymphoma.
NYU Langone launches a new heart transplant program.
Large national study shows the life-saving potential of coordinating EMS, hospital responses
A new study by NYU College of Global Public Health and the University of Michigan finds that the “obesity paradox” is not present among people with new cases of cardiovascular disease.
Stress in early life may change the immune response in the kidneys, increasing the risk of heart disease later in life, according to a new study.
Study of Electrocardiogram Readings in National Basketball Association (NBA) Players Highlights Value of Sport-Specific Normative Data and Guidelines. The findings were published on Dec. 6 in JAMA Cardiology.
A team of gene therapy researchers has reported positive results in a phase 1/2 clinical trial for the inherited bleeding disorder hemophilia B. A single intravenous infusion of a novel bioengineered gene therapy treatment enabled adult participants to safely produce sustained levels of clotting factor that prevented debilitating bleeding episodes. Patients were able to terminate prophylactic treatments--the gene therapy nearly universally eliminated their need for intravenous infusions of manufactured clotting factor.
Using zebrafish mutants in four different estrogen receptors, Daniel Gorelick has found a novel mechanism of estrogen action on heart physiology. Broader use of the mutants, he says, may have significant implications for studies of estrogenic environmental endocrine disruptors.
High blood pressure (hypertension) is redefined for the first time in 14 years by the American College of Cardiology and American Heart Association Task Force on Clinical Practice Guidelines.
Reducing a protein found in the mitochondria of cardiac muscle cells initiates cardiac dysfunction and heart failure, a finding that could provide insight for new treatments for cardiovascular diseases, a study led by Georgia State University has shown.
A reindeer with a red glowing nose. A heart, two sizes two small, that suddenly grows three sizes. A trip to the past and to the future — all in one night. Researchers dug deep into their reserves of scientific expertise to explain how these inexplicable plot lines in holiday classics just might be (almost) possible:
Led by researchers in the Smith Center for Outcomes Research in Cardiology at Beth Israel Deaconess Medical Center (BIDMC), the large-scale analysis determined that 30 percent of readmissions following peripheral revascularization were related to complications associated with the procedure, while differences in hospital quality accounted only modestly for readmission risk.
Hackensack Meridian Health Riverview Medical Center in Red Bank, NJ is pleased to welcome vascular surgeon, Habib Khan, M.D., to the medical staff. Dr. Khan specializes in vascular surgery especially minimally invasive vascular surgery and joined the Hackensack Meridian Health Cardiovascular Network in August 2015, practicing at Jersey Shore University Medical Center in Neptune, NJ and Bayshore Medical Center in Holmdel, NJ, where he was named Physician of the Year in 2017.
BOSTON – (November 29, 2017) – Scientists at Joslin Diabetes Center have taken another step toward solving a long-standing puzzle about heart health in type 2 diabetes, with a finding that eventually may point towards more personalized patient care.People with type 2 diabetes, who are at least twice as likely to develop cardiovascular disease (CVD) as people without the condition, generally can reduce their risks by careful controlling their glycemic (blood glucose) levels.
Research led by scientists at the University of Birmingham shows more precisely how G protein-coupled receptors, which are the key target of a large number of drugs, work.
a powerful new computer model replicates the biological activity within the heart that precedes sudden cardiac death.
Physician-researchers from the Cardiac Center at Children’s Hospital of Philadelphia recently presented new findings on pediatric cardiovascular disease at the American Heart Association’s Scientific Sessions 2017 in Anaheim, Calif. Among many abstracts presented were research on racial disparities in bystander CPR methods in children with sudden cardiac arrest, and findings that children with hypertrophic cardiomyopathy may be at risk for sudden cardiac death.
People who have lived though natural disasters such as Hurricane Harvey are under a great amount of stress putting their lives back together. A cardiologist tells us that this type of stress, in a roundabout way, can do damage to the heart.
UT Southwestern researchers have identified a major mechanism by which obesity causes type 2 diabetes, which is a common complication of being overweight that afflicts more than 30 million Americans and over 400 million people worldwide.
Changing the prices of seven foods, including fruits, vegetables and sugar-sweetened beverages, could reduce annual deaths from stroke, diabetes and cardiovascular disease by 3-9 percent and address disparities in the United States.
The final results of the DAWN study, published in The New England Journal of Medicine, show that select patients with stroke caused by a blood clot can be effectively treated with a procedure to remove the clot mechanically – and that this can be done up to 24 hours after the onset of symptoms.
Less than one per cent of UK children born with congenital heart disease are enrolled in clinical trials looking to improve treatments, research by the University of Birmingham has found.
By reducing out-of-pocket costs for preventive treatment, the Affordable Care Act appears to have encouraged more people to have health screenings related to their cardiovascular health, a UCLA study found.
New research by UT Southwestern cardiologists counters long-held beliefs that hospitals performing greater numbers of heart valve surgeries have better outcomes.
A study of more than 400 adults with prehypertension, or stage 1 high blood pressure, found that combining a low-salt diet with the heart-healthy DASH diet substantially lowers systolic blood pressure — the top number in a blood pressure test — especially in people with higher baseline systolic readings.
People with both HIV and risk factors for heart disease and stroke were less likely to be treated with cholesterol-lowering statin drugs and aspirin than patients without HIV.
Infants with various forms of congenital heart disease require a stable source of blood flow to their lungs in order to survive until a more definitive operation can be performed. In a recent study, pediatric researchers compared two methods to provide that flow: a shunt to reroute blood and an implanted stent to maintain an open path for blood flow. They found that stents were preferable for selected patients.
Mayo Clinic研究人员的工作显示患者使用不同类型的血液稀释药物来预防中风与其肾功能衰退或衰竭风险增加之间的联系。他们在“美国心脏病学院学报”（Journal of the American College of Cardiology）上发表的这项研究是旨在确定非维生素K拮抗剂(non-vitamin K antagonist)口服抗凝剂与长期以来的标准药物华法林(warfarin)相比的安全性和有效性的一系列研究（series of studies）中的最新的一项。患有房颤（atrial fibrillation）-- 中风的危险因素 --的患者通常会服用这类药物。
Mayo Clinic researchers have shown a link between which type of oral anticoagulant (blood-thinning medication) a patient takes to prevent a stroke and increased risks of kidney function decline or failure.
Dr. Anthony Furlan of University Hospitals in Cleveland was given the Neurologist Pioneering Award from the Society of Vascular and Interventional Neurology (SVIN).
By studying the genetic makeup of people who maintain clear arteries into old age, researchers led by UNC’s Jonathan Schisler, PhD, have identified a possible genetic basis for coronary artery disease (CAD), as well as potential new opportunities to prevent it.
A tool designed to more accurately predict the risk of heart attack in older patients undergoing non-cardiac surgery works significantly better than traditional risk assessment tools. By having more accurate information, older patients and their physicians can make an informed decision on whether to undergo surgery.
Swift action by two Army medical department officers from the Uniformed Services University of the Health Sciences saved the life of a Texas woman who went into cardiac arrest on Veterans Day.
Heart attack and stroke patients without medical insurance face “devastating” health care costs that can bankrupt them, research from UT Southwestern and other centers shows.
Ganesh Halade has published a functional and structural compendium of the simultaneous changes taking place in the heart, spleen and kidneys in mice during the period of acute heart failure immediately following a heart attack and during the longer period of chronic heart failure that comes next.
A stem cell therapy did not improve walking ability in people with peripheral artery disease, although exercise did lead to significant improvements, according to a new study. This is the largest trial of this type of therapy in people with blockages in leg arteries. Scientists were disappointed that stem cell therapy didn’t improve walking, because earlier research suggested it could be beneficial.
Anaheim Convention Center Anaheim, California Nov. 11-15
After boys and young men with Duchenne muscular dystrophy received cardiac progenitor cell infusions, medical tests indicated that the patients’ hearts appeared improved, results from a new study show. Patients in the study also scored higher on arm strength tests after receiving the cell infusions.
Texas Biomedical Research Institute scientists have been granted funding from the National Institutes of Health to pursue a promising study on the ultimate causes of heart disease and metabolic disorders.
A los científicos del Texas Biomedical Research Institute (Instituto de Investigación Biomédica de Texas) les han otorgado una beca por parte del National Institutes of Health (NIH) (Institutos Nacionales de Salud) para llevar a cabo un estudio prometedor sobre las causas principales de enfermedades del corazón y los trastornos metabólicos.
The American Heart Association (AHA) and Lawrence Livermore National Laboratory (LLNL) have formed a strategic business partnership to overcome the burden of drug discovery, cost and access.
Researchers from Case Western Reserve University School of Medicine, Vanderbilt University, and University of Pittsburgh have received a four-year, $9 million grant from the National Institutes of Health to develop enhanced infrared light technology (infrared neuromodulation) for potentially treating a variety of diseases, including cardiac arrhythmias, high and low blood pressure, asthma, sleep apnea and diarrhea, one of the leading killers of children worldwide.
Patients who go to the emergency room (ER) with chest pain often receive unnecessary tests to evaluate whether they are having a heart attack, a practice that provides no clinical benefit and adds hundreds of dollars in health-care costs, according to a new study from researchers at Washington University School of Medicine in St. Louis.
Patients showed a reduction in measures of frailty after surgery for left-ventricular-assist-device (LVAD)
Individuals who have A, B, or AB blood types have an elevated risk of having a heart attack during periods of significant air pollution, compared to those with the O blood type, according to a new study from the Intermountain Medical Center Heart Institute and Brigham Young University.
New research from the University of Maryland School of Medicine suggests that the system for choosing transplant recipients in chronic obstructive pulmonary disease (COPD) may underestimate how long a person might survive without a lung transplant and therefore, may mislead clinicians.
RSS
Medicine keyboard_arrow_right
Sciencekeyboard_arrow_right
Life keyboard_arrow_right
Business keyboard_arrow_right
Journal News keyboard_arrow_right
By Location keyboard_arrow_right
Meetings, Grants, and Events keyboard_arrow_right